VolitionRx Ltd
VNRX
7 hedge funds and large institutions have $3.38M invested in VolitionRx Ltd in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.01% less ownership
Funds ownership: 0.25% → 0.24% (-0.01%)
8% less capital invested
Capital invested by funds: $3.66M → $3.38M (-$280K)
30% less funds holding
Funds holding: 10 → 7 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$6.73K |
| 2 |
Morgan Stanley
New York
|
+$3.78K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$82K |
| 2 |
SIM
Spark Investment Management
New York
|
-$72K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$151 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SCA
1
Southpoint Capital Advisors
New York
| $3.16M | – | – | – |
|
|
GBA
2
Garrison Bradford & Associates
New York
| $61K | – | – | – |
|
|
CS
3
Credit Suisse
Zurich,
Switzerland
| $47K | – | – | – |
|
|
4
Morgan Stanley
New York
| $46K | +$3.78K | +50 | +10% |
|
|
CA
5
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
| $45K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $17K | +$6.73K | +89 | +67% |
|
|
VKH
7
Virtu KCG Holdings
New York
| – | -$82K | -999 | Closed |
|
|
SIM
8
Spark Investment Management
New York
| – | -$72K | -880 | Closed |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| – | -$151 | -2 | -40% |
|
VNRX Hedge Fund Activity: Q2 2015 in Review
7 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q2 2015, worth a combined $3.38M — down 7.7% from $3.66M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of VNRX and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was UBS Group, adding an estimated $6.73K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $82K sold.
- 7 institutional investors held VolitionRx Ltd (VNRX) as of Q2 2015, down from 10 in Q1 2015.
- Funds reported $3.38M of VolitionRx Ltd stock for Q2 2015, down 7.7% quarter-over-quarter.
- 0 funds opened new VolitionRx Ltd positions in Q2 2015 and 3 closed out, a net change of -3 holders.
- The largest VolitionRx Ltd buyer in Q2 2015 was UBS Group, an estimated $6.73K added.
- The largest VolitionRx Ltd seller in Q2 2015 was Virtu KCG Holdings, an estimated $82K sold.
Based on aggregated 13F filings for Q2 2015.